Lead Product(s) : Silver Citrate
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase I/ Phase II
Sponsor : Texas A&M University
Deal Size : Inapplicable
Deal Type : Inapplicable
CelAgaceâ„¢ OraRinse Solution for Treatment of Candidiasis
Details : Silver Citrate is a Other Small Molecule drug candidate, which is currently being evaluated in phase I/ phase II clinical studies for the treatment of Candidiasis, Oral.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
August 16, 2017
Lead Product(s) : Silver Citrate
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase I/ Phase II
Sponsor : Texas A&M University
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
